Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Myointimal hyperplasia: basic science and clinical considerations

R F Neville1, A N Sidawy

  • 1Department of Surgery, Veterans Affairs Medical Center, George Washington University, Washington, DC, USA.

Seminars in Vascular Surgery
|October 8, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Benchmarking a Center of Excellence in Vascular Surgery: Using Acute Physiology and Chronic Health Evaluation II to Validate Outcomes in a Tertiary Care Institute.

Vascular and endovascular surgery·2023
Same author

Correction: critical interactions between TGF-β signaling/ELF, and E-cadherin/β-catenin mediated tumor suppression.

Oncogene·2021
Same author

Physiological, physical and behavioural changes in dogs (Canis familiaris) when kennelled: testing the validity of stress parameters.

Physiology & behavior·2014
Same author

An expanded series of distal bypass using the distal vein patch technique to improve prosthetic graft performance in critical limb ischemia.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2012
Same author

Critical interactions between TGF-beta signaling/ELF, and E-cadherin/beta-catenin mediated tumor suppression.

Oncogene·2005
Same author

Evaluation of urinary TBARS in normal and chronic laminitic ponies.

Equine veterinary journal·2004

Mechanical injury from vascular procedures can cause myointimal hyperplasia, a key factor in bypass failure and restenosis. Understanding its pathogenesis may lead to new therapies targeting growth factors like PDGF.

Area of Science:

  • Vascular Biology
  • Pathology
  • Regenerative Medicine

Background:

  • Myointimal hyperplasia (MIH) is a pathological vascular process.
  • It is initiated and maintained by mechanical injury from procedures like angioplasty and bypass surgery.
  • MIH is a major cause of bypass graft failure and restenosis after angioplasty.

Purpose of the Study:

  • To review the basic physiology of myointimal hyperplasia.
  • To discuss potential future therapeutic strategies for MIH.

Main Methods:

  • Literature review of myointimal hyperplasia.
  • Analysis of growth factor involvement in vascular smooth muscle cell proliferation.

Main Results:

  • Mechanical and chemical factors induce MIH.

Related Experiment Videos

  • Arterial injury stimulates growth factors (e.g., PDGF) that promote smooth muscle cell proliferation.
  • Antibodies against growth factors (e.g., PDGF, FGF) can limit hyperplastic lesion development.

    • Conclusions:

    • Myointimal hyperplasia is a complex process driven by vascular injury and growth factors.
    • Targeting growth factor pathways presents a promising therapeutic avenue for preventing bypass failure and restenosis.